STATE OF ERECTILE FUNCTION IN MEN WITH PRIMARY HYPOTHYROIDISM
DOI:
https://doi.org/10.11603/1811-2471.2018.v0.i1.8644Keywords:
primary hypothyroidism, erectile dysfunction, obesity.Abstract
Erectile dysfunction (ED) as inability to attain and/or support penile erection sufficient for realization of satisfactory sexual intercourse in men after 40-years-old age is one of the most frequent general chronic disorders.
The aim of the study – to estimate an erectile function on a scale «The International index of erectile function (IIEF) – 15» for men with a primary hypothyroidism, that were on stationary and ambulatory treatment in Ternopil University Hospital.
Materials and Methods. Analysis of the state of erectile function in men with hypothyroidism conducted the «The International index of erectile function – 15» (IIEF). 60 men with primary hypothyroidism in age from 21 to 75 years were under observation.
Results. ED was significantly more often meets in patients with hypothyroidism (43 of 60 men, 72.0 %), what in men from a control group. The significant decrease decline of all integrative indexes of IIEF-15 was set in men with hypothyroidism by comparison to the indexes of patients in control group. The results of questionnaire of the inspected patients specify on hypothyroidism as on a direct factor that negatively influences on a sexual function in men.
Conclusions. An analysis of results of IIEF-15 questionnaire in men with hypothyroidism, ED and educed the expressed decline of all indexes of erectile function and androgen deficiency at inspected both groups by comparison to control. Calculation of integrative indexes of the state of sexual function in inspected men with hypothyroidism, significant decrease showed an androgen deficiency and obesity or normal body weight for them all parameters comparatively with a control group.
References
Brody, S. (2010). The relative health benefits of different sexual activities. Journal of Sexual Medicine, 7, 1336-1361. doi: 10.1111/j.1743-6109.2009.01677.x
Skeldon, S.C., Cheng, L., Morgan, S.G., Detsky, A.S., Goldenberg, S.L., Law, M.R. (2017). Erectile dysfunction medications and treatment for cardiometabolic risk factors: a pharmacoepidemiologic study. J. Sex Med., 14 (12), 1597-1605. doi: 10.1016/j.jsxm.2017.10.063.
Izza, E.F., & Rosen, R.C. (1999). Definition and classification of erectile dysfunction:reportofthe Nomenclature Committee of the International Society of Impotence Research. Int. J. Impot. Res., 11, 141-143.
Oyelade, B.O., Jemilohun, A.C., & Aderibigbe, S.A. (2016). Prevalence of erectile dysfunction and possible risk factors amongmen of South-Western Nigeria: a population based study. Pan. Afr. Med. J., 24, 124. doi: 10.11604/ pamj.2016.24.124.8660. e Collection 2016.
Quilter, M., Hodges, L., von Hurst, P., Borman, B., & Coad, J. (2017). Male sexual function in New Zealand: a population-based cross-sectional survey of the prevalence of erectile dysfunction in men aged 40-70 years. J. Sex Med., 14 (7), 928-936. doi:10.1016/j.jsxm.2017.05.011.
Meena, B.L., Kochar, D.K., Agarwal, T.D., & Choudhary, R., Kochar, A. (2009). Association between erectile dysfunction and cardiovascularris kinindividuals with type2 diabetes with outovertcardiovascular disease. Int. J. Diabetes Dev. Ctries, 29 (4), 150-154. doi: 10.4103/0973-
57345.
Gandaglia, G., Briganti, A., Jackson, G., Kloner, R.A., Montorsi, F., Montorsi, P., & Vlachopoulos, C. (2014). A system aticle view of the association between erectile dysfunction and cardiovascular disease. Eur. Urol., 65 (5), 968-978. doi: 10.1016/j.eururo.2013.08.023.
Kaya, E., Sikka, S.C., & Gur, S. (2015). A comprehensive view of metabolic syndrome aff gerectile dysfunction. J. Sex Med., 12 (4), 856-875. doi: 10.1111/jsm.12828.
Iacona, R., Bonomo, V., Di Piazza, M., Sansone, A., Usala, M., Novo, S., & Pavone, C. (2017). Fiveyear prospective studyon cardiovasculare vents, in patients with erectile dysfunction and hypotestosterone. Arch. Ital. Urol. Androl., 89 (4), 313-315. doi: 10.4081/aiua.2017.4.313.
Zhang, X., Yang, B., Li, N., & Li, H. (2017). Prevalence and risk factors for erectile dysfunction in Chinese adult males. J.SexMed.,14(10),1201-1208.doi:10.1016/j.jsxm.2017.08.009.
Nikoobakht, M.R., Aloosh, M., Nikoobakht, N., Mehrsay, A.R., Biniaz, F., & Karjalian, M.A. (2012). Therole of hypothyroidism in male in fertility and erectile dysfunction. Urol. J., 9 (1), 405-409.
Bondarenko, V.O., & Spivak, Zh.S. (2014). Dosvid zastosuvannia levotyroksynu ta antyoksydantiv pry terapii neplidnosti v cholovikiv, khvorykh na hipotyreoz [Experience of levothyroxine and antioxidants in the treatment of infertility in men with hypothyroidism]. Mizhnarodnyi endokrynolohichnyi zhurnal – International Endocrinology Journal, 7 (63), 35-39 [in Ukrainian].
Keller, J., Chen, Y.K., & Lin, H.C. (2012). Hyperthy- roidism and erectile dysfunction: A population-based case- control study. International Journal of Impotence Research, 24 (6), 242-246. DOI: 10.1038/ijir.2012.24.
Grossmann, M., & Wu, F.C. (2014). Male androgen deficiency: a multisystem syndrome. Asian J. Androl., 16 (2), 159-160.
Chueh, K.S., Huang, S.P., & Lee, Y.C. (2012). The comparison of the aging male symptoms (AMS) and androgen deficiency in the aging male (ADM) question naire to detect androgen difiency in middleagedmen. J. Androl., 33 (5), 817-823.
Grossmann, M. (2014). Testoseterone and glucose metabolism in men: current concepts and controversies. J. Endocrinol., 220, 37-55.
